RE:RE:RE:RE:RE:RE:Slides up bio tech Yeah, unfortunately my president thinks out loud a lot too. I'm scared of what might come out of his mouth tonight. But seriously.....
December 31, 2018 = end of 2018 = Sept-Nov guidance on end of dosing/hitting 250 events; 2-3 months was the guidance on adjudication, after which comes top-line. So end of year dosing = very likely Q1 topline.
Today is January 8, 2019 = 8 days past end of 2018. 250 events/end of dosing not reach yet. But we're only 8 days off of the Sept-Nov guidance! The MD&A, Dec and Jan updates changed the wording to H1 end of dosing and/or H1 trial completion. Q1 is still in H1. If one takes the 3 month number in the 2-3 month adjuciation range, then one is into Q2 assuming dosing ends soon. Big deal!
Mountains out of mole hills. The sky is falling!
BearDownAZ